|Bid||23.94 x 1000|
|Ask||23.95 x 800|
|Day's Range||23.64 - 24.50|
|52 Week Range||8.34 - 31.28|
|Beta (5Y Monthly)||0.80|
|PE Ratio (TTM)||73.49|
|Earnings Date||Aug 02, 2021 - Aug 06, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||35.17|
Ladies and gentlemen, thank you for standing by, and welcome to the R1 RCM Q1 2021 Earnings Conference Call. Certain statements made during this call may be considered forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In particular, any statements about our future growth, plans and performance, including statements about our strategic and cost-saving initiatives, our liquidity position, our growth opportunities and our future financial performance are forward-looking statements.
Shares of R1 RCM (NASDAQ: RCM) had tumbled 12.6% as of 11:42 a.m. EDT on Tuesday. The decline came after the healthcare technology company announced its first-quarter results before the market opened. R1 RCM reported revenue of $342.6 million in the first quarter.
R1 RCM Inc. (RCM) delivered earnings and revenue surprises of -2270.00% and 1.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?